Comments on: Tips for surviving the market meltdown
Christopher Lochhead, the former chief marketing officer at Scient and Mercury, offers advice on how companies can thrive in the current economic meltdown.
Christopher Lochhead, the former chief marketing officer at Scient and Mercury, offers advice on how companies can thrive in the current economic meltdown.
Web sites launch all the time, but they also shut their doors. We highlight 15 that bit the dust this year.
Let the debate begin: Was the iPhone more important than iTunes? Was anything bigger than Google finding a great business model? CNET offers its list of the 10 most important stories of the '00s.
Dan Farber is the editor in chief of CNET News. He has covered technology for more than two decades, and he previously served as editor in chief of ZDNet, PC Week and MacWeek. Outside the Lines explores the intersection of business and technology.
Add this feed to your online news reader
Editors Dan Farber of News.com and Larry Dignan of ZDNet, square off in EIC² in this weekly podcast. The two editor in chiefs talk about the big tech stories of the day and provide insight and analysis.
Subscribe to this podcast using an RSS reader other than iTunes
Subscribe to this podcast using iTunes
The message here wasn?t to invest in stocks; it was to invest in technology. Continually pushing ahead, innovation, being a leader and not a follower. However, innovation is expensive, and it?s also important to focus more now than ever on the economies of scale, how can I still do more with less, where is the ?fat? in my company, prioritize and focus on where to invest and reduce the number of areas you diversify in.
And, yes buying tech companies. Many have great ideas, but will struggle through today?s market and look for an opportunity to get out cheap.
- by fdunn3 October 9, 2008 4:45 PM PDT
- The only good tip is to ride it out. Stocks aren't for the short term (although in the last few years you wouldn't know that) or the faint of heart.
- Like this Reply to this comment
-
(4 Comments)